Detalhe da pesquisa
1.
Development and Validation of the DOAC Score: A Novel Bleeding Risk Prediction Tool for Patients With Atrial Fibrillation on Direct-Acting Oral Anticoagulants.
Circulation
; 148(12): 936-946, 2023 09 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-37621213
2.
Recurrent venous thromboembolism and bleeding with extended anticoagulation: the VTE-PREDICT risk score.
Eur Heart J
; 44(14): 1231-1244, 2023 04 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36648242
3.
Treatment of Cancer-Associated Thrombosis: Recent Advances, Unmet Needs, and Future Direction.
Oncologist
; 28(7): 555-564, 2023 07 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37171998
4.
Oral anticoagulation across diabetic subtypes in patients with newly diagnosed atrial fibrillation: A report from the GARFIELD-AF registry.
Diabetes Obes Metab
; 25(10): 3040-3053, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37435777
5.
Rivaroxaban for Thromboprophylaxis in High-Risk Ambulatory Patients with Cancer.
N Engl J Med
; 380(8): 720-728, 2019 02 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-30786186
6.
The importance of the design of observational studies in comparative effectiveness research: Lessons from the GARFIELD-AF and ORBIT-AF registries.
Am Heart J
; 243: 110-121, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34529945
7.
Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism.
N Engl J Med
; 378(7): 615-624, 2018 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-29231094
8.
Response by Aggarwal et al to Letter Regarding Article, "Development and Validation of the DOAC Score: A Novel Bleeding Risk Prediction Tool for Patients With Atrial Fibrillation on Direct-Acting Oral Anticoagulants".
Circulation
; 149(16): e1111-e1112, 2024 Apr 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38620083
9.
Early Risks of Death, Stroke/Systemic Embolism, and Major Bleeding in Patients With Newly Diagnosed Atrial Fibrillation.
Circulation
; 139(6): 787-798, 2019 02 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30586740
10.
Fundamental Research in Oncology and Thrombosis 2 (FRONTLINE 2): A Follow-Up Survey.
Oncologist
; 25(7): e1091-e1097, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32384216
11.
Rivaroxaban or Aspirin for Extended Treatment of Venous Thromboembolism.
N Engl J Med
; 376(13): 1211-1222, 2017 03 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-28316279
12.
Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease.
N Engl J Med
; 377(14): 1319-1330, 2017 10 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-28844192
13.
Safety of Proton Pump Inhibitors Based on a Large, Multi-Year, Randomized Trial of Patients Receiving Rivaroxaban or Aspirin.
Gastroenterology
; 157(3): 682-691.e2, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31152740
14.
Machine learning does not improve upon traditional regression in predicting outcomes in atrial fibrillation: an analysis of the ORBIT-AF and GARFIELD-AF registries.
Europace
; 22(11): 1635-1644, 2020 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32879969
15.
The association between patterns of atrial fibrillation, anticoagulation, and cardiovascular events.
Europace
; 22(2): 195-204, 2020 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31747004
16.
Cancer associated thrombosis in everyday practice: perspectives from GARFIELD-VTE.
J Thromb Thrombolysis
; 50(2): 267-277, 2020 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-32583306
17.
Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial.
Lancet
; 391(10117): 219-229, 2018 01 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-29132880
18.
Predictors of NOAC versus VKA use for stroke prevention in patients with newly diagnosed atrial fibrillation: Results from GARFIELD-AF.
Am Heart J
; 213: 35-46, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31128503
19.
International longitudinal registry of patients with atrial fibrillation and treated with rivaroxaban: RIVaroxaban Evaluation in Real life setting (RIVER).
Thromb J
; 17: 7, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31169831
20.
Characteristics of patients with atrial fibrillation prescribed antiplatelet monotherapy compared with those on anticoagulants: insights from the GARFIELD-AF registry.
Eur Heart J
; 39(6): 464-473, 2018 02 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29281086